Learn how you can stall the development of full-blown Multiple Myeloma with evidence-based nutritional and supplementation therapies.
Click the orange button to the right to learn more.
Smoldering multiple myeloma is a plasma cell disorder defined by the presence of a serum monoclonal component of at least 30 g/L and/or between 10% and 60% plasma cells in the bone marrow. Dear David-
Continue reading“Several lines of evidence point to a genetic predisposition to Multiple Myeloma and other plasma cell dyscrasias.” Hi David- Thanks for this information as it seems to be the only one of
Continue readingthe risk of progression to a symptomatic disease. (MGUS diagnosis) progression risk is approximately 1% per year, and SMM has a risk of progression of 10% for the first 5 years which tapers off over time. Hi
Continue reading“As with MGRS, patients with smoldering myeloma (SMM) are asymptomatic but have higher MIg levels and BMPCs.” Hi David- I have been diagnosed with Smoldering Multiple Myeloma 3 months ago.
Continue readingYes, the effectiveness of apixaban (Eliquis), rivaroxaban (Xarelto), betrixaban (Bevyxxa), and other anticoagulant drugs (blood-thinners) classified as “direct factor Xa inhibitors” may be
Continue reading“Non-IgM MGUS is considered a preneoplastic condition with an annual risk of progression of approximately 1%. Risk of progression is increased when M protein greater than or equal to 15 g/L and with
Continue reading“Cancer treatment can be debilitating, but there may be ways patients can better prepare themselves for the challenges to come…” Hello David- I believe I was diagnosed with monoclonal
Continue readingBecause they do not meet conditions for smoldering multiple myeloma or MM, these patients are mistakenly diagnosed as MGUS (or pre-myeloma) While the studies linked below are confusing at best, it is
Continue reading“In addition, a common genetic susceptibility for developing both an autoimmune disease and MM/MGUS might also exist.” Hi David- I recently received a monoclonal gammopathy of undetermined
Continue readingSadly, from a diagnosis standpoint, pre-myeloma conditions are viewed as a sort of red-headed stepchild to multiple myeloma. Meaning, oncology focuses on tests for monoclonal proteins and how they might
Continue readingMonoclonal Gammopathy of Undetermined Significance aka MGUS is not cancer. It is considered to be a “blood disorder” or pre-multiple myeloma. Hello David: Great work you are doing to get us
Continue reading“Individuals with low-risk/intermediate-risk MGUS can convert to high-risk MGUS and progress to multiple myeloma within five years…” I think it makes sense that serum immune markers of
Continue reading